telbivudine has been researched along with AIDS Seroconversion in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbott, WG; Ge, J; Hou, J; Huang, X; Huang, Z; Jiang, X; Lai, Q; Li, Y; Ma, S; Sun, J; Zhang, M; Zhang, X | 1 |
1 other study(ies) available for telbivudine and AIDS Seroconversion
Article | Year |
---|---|
TCRγδ(+)CD4(-)CD8(-) T cells suppress the CD8(+) T-cell response to hepatitis B virus peptides, and are associated with viral control in chronic hepatitis B.
Topics: Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cohort Studies; Cross-Sectional Studies; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Seropositivity; Humans; Liver; Lymphocyte Count; Male; Peptides; Receptors, Antigen, T-Cell, gamma-delta; Telbivudine; Thymidine; Young Adult | 2014 |